Skip to content

Author: Women's Health Partners, LLC

Celebrate National Midwifery Week with a $100 Target Gift Card!

Enter our raffle by sharing about your experience with one of our incredible midwives!

National Midwifery Week 2018

Please submit your story on our Midwive’s Facebook page to be eligible for the gift card. To visit their Facebook page, click here.

Our midwives are thrilled to be part of such an incredible process in the lives of our patients, and we hope you will help us to celebrate them and all that they do over the next week!

 

Influenza Vaccine and Pregnancy

We strongly recommend that pregnant women be vaccinated for seasonal flu. 

Please call our office to schedule your Flu shot, if you have not received it yet.

Influenza is more likely to cause severe illness in pregnant women than in women who are not pregnant. Pregnant women have a higher risk for serious complications from influenza than non-pregnant women.

The Influenza vaccine will protect pregnant women, their unborn babies, and protect the baby after birth. The risk for a pregnant woman and her unborn baby of getting sick with the flu is far greater than being vaccinated. If you did not get the Influenza vaccine during your pregnancy, you should still get vaccine even if you are breast feeding. This will help prevent you and your baby from getting the flu.

There are some people who should not get any flu vaccine without first consulting a physician. These include:  

  • People who have a severe allergy to chicken eggs.
  • People who have had a severe reaction to an influenza vaccination.
  • People who developed Guillain-Barré syndrome within 6 weeks of getting an influenza vaccine previously.
  • Children younger than 6 months of age (influenza vaccine is not approved for this age group).
  • People who have a moderate-to-severe illness with a fever (they should wait until they recover to get vaccinated).

Here are some useful Links:

Center for Disease Control (Seasonal Flu Vaccine Safety and Pregnant Women)

Center for Disease Control (Key Facts About Seasonal Flu Vaccine)

10 Symptoms of Endometriosis You Should Be Aware Of

Many women with living with endometriosis do not even realize that they have it. Sexual health can be a bit of a touchy topic that leaves many women feeling embarrassed about their body, but there is absolutely nothing to be ashamed of, and speaking up will only help to improve both the quality and longevity of your life.

Continue reading “10 Symptoms of Endometriosis You Should Be Aware Of”

Taytulla – Birth Control Pill Recall

Allergan Issues Nationwide Voluntary Recall of TAYTULLA® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules.
 
Allergan issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6×28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules.

Incorrectly Packaged TAYTULLA

As a result of this packaging error, oral contraceptive capsules, that are taken out of sequence, may place the user at risk for contraceptive failure and unintended pregnancy. The reversing of the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the capsules out of order. If patients have concerns regarding the possibility of an unintended pregnancy they should consult their physician.

This product is an oral contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives. The TAYTULLA  pill pack is a 28 count blister card that has 24 “active” pink softgel capsules (with hormones) with “WC” printed on the outer shell in white to be taken for 24 days, followed by 4 maroon softgel capsules (without hormones) also imprinted with “WC” on one side to be taken for the next four days. If you are a patient in the U.S. who has used a TAYTULLA sample pack from lot 5620706, Exp. May 2019 since August 27, 2017, and are concerned that you may be impacted by this issue, please consult with your physician. This product was distributed Nationwide to healthcare providers.

Please refer to the affected lot number as well as the pictures below of the affected product.

Allergan is notifying customers by recall letter and is arranging for return of all recalled sample pack product with the lot #5620706 Exp. May 2019. Consumers who have the sample pack product with the associated lot number should notify their physician to arrange a return.  

Consumers with questions regarding this recall can contact Allergan by phone at 800-678-1605 8am-8pm EST Monday through Friday. Consumers should contact their physician or healthcare provider if they have questions.

For more information about TAYTULLA and the full prescribing information, please visit www.taytulla.com.

Company Contact:  1-800-678-1605

Correctly Packaged TAYTULLA